14-May-2019: The global metagenomics market size is expected
to reach USD 1.40 billion by 2025, according to a new report by Grand View
Research, Inc., exhibiting a CAGR of 16.6% during the forecast period. Rise in
demand for microbial screening in food and chemical industries for commercial
applications, coupled with rapid developments in bioinformatics and
biotechnology tools, is anticipated to accelerate market growth in the coming
years.
Key market participants are
striving to capitalize potential avenues in the market by addressing challenges
faced by research entities pertaining to data assembly, identification, and
verification of rare metagenomes. Furthermore, companies operating in the
molecular diagnostics and genomics arena are a playing crucial role in this market
by partnering with metagenomics companies for development of novel tests for
disease diagnosis.
For instance, in September
2017, IDbyDNA, Inc. and ARUP Laboratories co-developed Explify Respiratory-a
metagenomic NGS test for screening of respiratory infections. The anticipated
launch of many such novel tests is projected to boost the market during the
forecast period.
In depth research report on Metagenomics Market
Further
key findings from the report suggest:
· Kits
and reagents formed the largest segment by product in 2017 owing to frequent
usage at various steps in microbial genomic studies
· Surplus
growth in genomics database with respect to types and numbers has led to rising
demand for better data analysis solutions. As a result, the sequencing and data
analytics services segment is expected to emerge as a lucrative source of
revenue generation during the forecast period
· Function
driven technology held the major revenue share in 2017. Development of new
screening procedures that facilitate rapid screening of large clone libraries
has enabledfunctional detection of novel enzymes from metagenomes
· Advancements
in genetic tools have broadened the application scope of metagenomics to
include targeting microbes responsible for inducing various cancer forms. This,
in turn, is driving the application of metagenomic analysis in human health
· North
America dominated the market in 2017. Strong presence of key NGS leaders like
Illumina and a substantial number of ongoing genomics-related studies in U.S.
are major factors contributing to its large share
· Some of
the key competitors in the market are Illumina, Inc.; Promega Corporation;
Novogene Corporation; Oxford Gene Technology, Inc.; Thermo Fisher Scientific,
Inc.; TAKARA BIO INC.; Danaher; QIAGEN; and ELITechGroup
· Acquisition
of small players with a strong product portfolio is a prominently adopted
strategy by dominant players. For instance, in August 2016, PerkinElmer
acquired Bioo Scientific Corporation-provider of 16S & 18S library
preparation kits for metagenome studies
· Competitors
are also involved in collaborations with bioinformatics companies for
co-development of novel platforms for metagenomics analysis.
Grand View Research has
segmented the global metagenomics market on the basis of product, technology,
application, and region:
Metagenomics
Product Outlook (Revenue, USD Million, 2014 - 2025)
· Kits
& Reagents
· Sequencing
& Data Analytics Services
· Others
Metagenomics
Technology Outlook (Revenue, USD Million, 2014 - 2025)
· Sequencing
Driven
· Function
Driven
Metagenomics
Application Outlook (Revenue, USD Million, 2014 - 2025)
· Environmental
· Human
Health
· Others
Browse
more research reports of this category:
About
Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, the company offers market
intelligence studies ensuring relevant and fact-based research across a range
of industries including technology, chemicals, materials, healthcare and
energy.
No comments:
Post a Comment